I agree TheSpaniard the share market is hard to read and can be...

I agree TheSpaniard the share market is hard to read and can be very challenging, but we need to stay on track and the facts are that PTX100 Phase 1 was very effective in regard to treatment results and safety. PTX100 Phase 2 statistically should have better results than Phase 1, as we are starting our treatments with healthier patients that may have only had 1 or 2 prior treatments with chemotherapy instead of 4/5 treatments. It is very likely that the results from PTX100 treatments will be promising and consistent whether it be in AUS or USA or Europe, let's not be confused good Cancer results are welcomed in any Country by Governments and Oncologists. Prof Miles Prince is the perfect person to run this program as he is a world leader in this field, l think in 6 months from now there will be some lives saved or at least substantially extended, and the flow on effect will be PTX shareholders being rewarded.